Your browser doesn't support javascript.
loading
Risk of dipeptidyl peptidase-4 (DPP-4) inhibitors on site-specific cancer: A systematic review and meta-analysis.
Overbeek, Jetty A; Bakker, Marina; van der Heijden, Amber A W A; van Herk-Sukel, Myrthe P P; Herings, Ron M C; Nijpels, Giel.
Afiliação
  • Overbeek JA; Department of General Practice and Elderly Care Medicine, Amsterdam Public Health Research Institute, VU University Medical Centre, Amsterdam, Netherlands.
  • Bakker M; PHARMO Institute for Drug Outcomes Research, Utrecht, Netherlands.
  • van der Heijden AAWA; PHARMO Institute for Drug Outcomes Research, Utrecht, Netherlands.
  • van Herk-Sukel MPP; Department of General Practice and Elderly Care Medicine, Amsterdam Public Health Research Institute, VU University Medical Centre, Amsterdam, Netherlands.
  • Herings RMC; Department of Internal Medicine and Dermatology, University Medical Center Utrecht, Utrecht, Netherlands.
  • Nijpels G; PHARMO Institute for Drug Outcomes Research, Utrecht, Netherlands.
Diabetes Metab Res Rev ; 34(5): e3004, 2018 07.
Article em En | MEDLINE | ID: mdl-29573125

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV / Neoplasias Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Diabetes Metab Res Rev Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Holanda

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV / Neoplasias Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans Idioma: En Revista: Diabetes Metab Res Rev Assunto da revista: ENDOCRINOLOGIA / METABOLISMO Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Holanda